Abbisko Therapeutics' PIMJETMI receives US FDA approval to treat tenosynovial giant cell tumour (TGCT)

bioMérieux secures FDA clearance and IVDR CE marking for VITEK PRO diagnostic platform

Compass Pathways completes FDA application for COMP360 in treatment-resistant depression

bioMérieux secures FDA clearance for updated gastrointestinal diagnostic panels

Photocure maintains 2028 Medicare coverage target for AssureMDx following CMS update

RYBREVANT FASPRO co-formulated with Halozyme's ENHANZE technology approved by US FDA in advanced head and neck cancer

Johnson & Johnson reveals new Phase 2 nipocalimab study data in Sjögren's disease

SK Biopharmaceuticals submits cenobamate supplemental New Drug Application to US FDA

Agilent acquires Proscia for USD240m

BeOne Medicines wins FDA Priority Review for BRUKINSA combination in first-line mantle cell lymphoma

United Therapeutics eliminates Pfizer royalty obligations on ralinepag for USD525m

Pentixapharm advances preparationsfor Phase 3 PANDA study

StimLabs launches DermaForm collagen scaffold particulate device

Merck launches Phase 3 trial of Ohtuvayre for COPD exacerbation prevention

Vivesto secures US orphan drug designation for Cantrixil in acute myeloid leukemia